Search research articles
Contact Us
Filters
Showing results (261-270 of 558) with videos related to
Page
of 56
Sort By:
Stroke
|
January 1, 1986
Major cerebral arterial and venous disease in osteopetrosis
G J Makin, R K Coates, D Pelz, et al.
Journal of Chemical Ecology
|
August 12, 2004
Induced defensive response of myrtle oak to foliar insect herbivory in ambient and elevated CO2
Anthony M Rossi, Peter Stiling, Daniel C Moon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
T J Vyse, S J Rozzo, C G Drake, et al.
Pediatric Radiology
|
January 1, 1993
A complete ileo-tumor-colic fistula in a child with Burkitt's lymphoma
C L Moertel, J Watterson, D G Drake, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 1999
A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets
D A Jaffray, D G Drake, M Moreau, et al.
Applied and Environmental Microbiology
|
August 30, 2002
Influence of elevated CO(2) on the fungal community in a coastal scrub oak forest soil investigated with terminal-restriction fragment length polymorphism analysis
Morten Klamer, Michael S Roberts, Lanfang H Levine, et al.
Immunological Reviews
|
April 1, 1995
Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice
C G Drake, S J Rozzo, T J Vyse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2011
Prostate cancer immunotherapy
Kenneth F May, James L Gulley, Charles G Drake, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2014
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
Raju R Raval, Andrew B Sharabi, Amanda J Walker, et al.
Journal of Clinical Pharmacology
|
October 11, 2003
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes
B K Skrumsager, K K Nielsen, M Müller, et al.
Page
of 56
Search research articles
Search
Showing results (261-270 of 558) with videos related to
Sort By:
Page
of 56
Stroke
|
January 1, 1986
Major cerebral arterial and venous disease in osteopetrosis
G J Makin, R K Coates, D Pelz, et al.
Journal of Chemical Ecology
|
August 12, 2004
Induced defensive response of myrtle oak to foliar insect herbivory in ambient and elevated CO2
Anthony M Rossi, Peter Stiling, Daniel C Moon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
T J Vyse, S J Rozzo, C G Drake, et al.
Pediatric Radiology
|
January 1, 1993
A complete ileo-tumor-colic fistula in a child with Burkitt's lymphoma
C L Moertel, J Watterson, D G Drake, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 1999
A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets
D A Jaffray, D G Drake, M Moreau, et al.
Applied and Environmental Microbiology
|
August 30, 2002
Influence of elevated CO(2) on the fungal community in a coastal scrub oak forest soil investigated with terminal-restriction fragment length polymorphism analysis
Morten Klamer, Michael S Roberts, Lanfang H Levine, et al.
Immunological Reviews
|
April 1, 1995
Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice
C G Drake, S J Rozzo, T J Vyse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2011
Prostate cancer immunotherapy
Kenneth F May, James L Gulley, Charles G Drake, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2014
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
Raju R Raval, Andrew B Sharabi, Amanda J Walker, et al.
Journal of Clinical Pharmacology
|
October 11, 2003
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes
B K Skrumsager, K K Nielsen, M Müller, et al.
Page
of 56